TSPO and cardiac arrhythmia: Although earlier studies showed that TSPO-acting ligands which reduced ROS levels were effective in abolishing metabolic and electrophysiological oscillations, their impact on arrhythmias in clinically relevant scenarios was not established until more recently [42].